Advertisement

Supportive Care in Cancer

, Volume 20, Issue 12, pp 3123–3127 | Cite as

A survey of the sedation practice of Portuguese palliative care teams

  • Ferraz GonçalvesEmail author
  • Aida Cordero
  • Ana Almeida
  • Arlindo Cruz
  • Céu Rocha
  • Madalena Feio
  • Paula Silva
  • Salomé Barbas
  • Sandra Neves
Original Article

Abstract

Aim

The purpose of this study is to study the practice of sedation by Portuguese palliative care teams.

Methods

The teams included on the website of the Portuguese Association for Palliative Care were invited to participate. Data from all the patients sedated between April and June 2010 were recorded. Sedation was defined as the intentional administration of sedative drugs for symptom control, except insomnia, independently of the consciousness level reached.

Results

Of the 19 teams invited only 4 actually participated. During the study period, 181 patients were treated: 171 (94 %) were cancer patients and 10 non-cancer patients. Twenty-seven (16 %) patients were sedated: 13 intermittently, 11 continuously, and 3 intermittently at first then continuously. The rate of sedation varied substantially among the teams. Delirium was the most frequent reason for sedation. Midazolam was the drug used in most cases. In 21 cases of sedation, the decision was made unilaterally by the professionals; in 16 (76 %) of those, the situation was deemed to be emergent. From the patients on continuous sedation, 9 (64 %) patients maintained oxygen, 13 (93 %) hydration, and 6 (43 %) nutrition. Two patients who had undergone intermittent sedation were discharged home and one was transferred to another institution; the reason for sedation in the three cases was delirium.

Conclusion

There is a substantial variation in the sedation rate among the teams. One of the most important aspects was the decision-making process which should be object of reflection and discussion in the teams.

Keywords

Sedation practice Portuguese Palliative care 

Notes

Acknowledgments

This work was supported in part by the North Section of the Portuguese League against Cancer.

Conflict of interests

None.

References

  1. 1.
    Cherny NI, Portenoy RK (1994) Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 10:31–38PubMedGoogle Scholar
  2. 2.
    Cherny NI (1998) Commentary: sedation in response to refractory existential distress: walking the fine line. J Pain Symptom Manage 16:404–407PubMedCrossRefGoogle Scholar
  3. 3.
    Ventafridda V, Ripamonti C, de Conno F, Tamburini M, Cassileth BR (1990) Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 6:7–11PubMedGoogle Scholar
  4. 4.
    Claessens P, Menten J, Schotsmans P, Broeckaert B (2008) Palliative sedation: a review of the research literature. J Pain Symptom Manage 36:310–333PubMedCrossRefGoogle Scholar
  5. 5.
    Ferraz Gonçalves J, Alvarenga M, Silva A (2003) The last forty-eight hours of life in a Portuguese palliative care unit: does it differ from elsewhere? J Palliat Med 6:895–900PubMedCrossRefGoogle Scholar
  6. 6.
    Chater S, Viola R, Paterson J, Jarvis V (1998) Sedation for intractable distress in the dying—a survey of experts. Palliat Med 12:255–269PubMedCrossRefGoogle Scholar
  7. 7.
    Morita T, Tsuneto S, Shima Y (2002) Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage 24:447–453PubMedCrossRefGoogle Scholar
  8. 8.
    Gonçalves F, Bento MJ, Alvarenga M, Costa I, Costa L (2008) Validation of a consciousness level scale for palliative care. Palliat Med 22:724–729PubMedCrossRefGoogle Scholar
  9. 9.
    Centeno C, Clark D, Lynch T, Rocafort J, Flores LA, Greenwood A, Brasch S, Praill D, Giordano A, de Lima L (2007) EAPC Atlas of palliative care in Europe. http://www.eapc-taskforce-development.eu/documents/taskforce/ATLAS-EAPC-2007.pdf. Access 5 November 2011.
  10. 10.
    Elsayem A, Curry E III, Boohene J, Munsell MF, Calderon B, Hung F, Bruera E (2009) Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center. Support Care Cancer 17:53–59PubMedCrossRefGoogle Scholar
  11. 11.
    Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY (2001) Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 21:467–472PubMedCrossRefGoogle Scholar
  12. 12.
    Sykes N, Thorns A (2003) The use of opioids and sedatives at the end of life. Lancet Oncol 4:312–318PubMedCrossRefGoogle Scholar
  13. 13.
    Berger JT (2010) Rethinking guidelines for the use of palliative sedation. Hasting Center Report 40:32–38CrossRefGoogle Scholar
  14. 14.
    Fainsinger RL, Waller A, Bercovici M et al (2000) A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 14:257–265PubMedCrossRefGoogle Scholar
  15. 15.
    Sales JP, Boré YC, Gil AE et al (1999) Estudio multicéntrico catalano-balear sobre la sedación terminal en Cuidados Paliativos. Pal Med 6:153–158Google Scholar
  16. 16.
    Olsen ML, Swetz KM, Mueller PS (2010) Ethical decision making with end-of-life care: palliative sedation and withholding or withdrawing life-sustaining treatments. Mayo Clin Proc 85:949–954PubMedCrossRefGoogle Scholar
  17. 17.
    Cherny NI, Radbruch L (2009) Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 23:581–593PubMedCrossRefGoogle Scholar
  18. 18.
    Reuz RPB, Hasselaar GJ, Vissers KCP, van der Wilt GJ, Groenewoud JMM, Crul BJP (2008) Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study. Palliat Med 22:641–646CrossRefGoogle Scholar
  19. 19.
    Hasselaar JGJ, Reuzel RPB (2007) PhD; Verhagen SCAHHVM, de Graeff A, MD, Vissers KCP, Crul BJP. Improving prescription in palliative sedation compliance with Dutch guidelines. Arch Intern Med 167:1166–1171PubMedCrossRefGoogle Scholar
  20. 20.
    Billings JA, Block S (1996) Slow euthanasia. J Palliat Care 12:21–30PubMedGoogle Scholar
  21. 21.
    Craig GM (1996) On withholding artificial hydration and nutrition from terminally ill sedated patients. The debate continues. J Med Ethics 22:147–153Google Scholar
  22. 22.
    Sykes N, Thorns A (2003) Sedative use in the last weeks of life and the implications for end-of-life decision making. Arch Intern Med 163:341–344PubMedCrossRefGoogle Scholar
  23. 23.
    Maltoni M, Pittureri C, Scarpi E, Piccini L, Martini F, Turci P, Montanari L, Nanni O, Amadori D (2009) Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol 20:1163–1169PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Ferraz Gonçalves
    • 1
    Email author
  • Aida Cordero
    • 2
  • Ana Almeida
    • 1
  • Arlindo Cruz
    • 3
  • Céu Rocha
    • 3
  • Madalena Feio
    • 4
  • Paula Silva
    • 1
  • Salomé Barbas
    • 2
  • Sandra Neves
    • 4
  1. 1.Unidade de Cuidados PaliativosInstituto Português de OncologiaPortoPortugal
  2. 2.Hospital de Santa LuziaElvasPortugal
  3. 3.Unidade Local de SaúdeMatosinhosPortugal
  4. 4.Instituto Português de OncologiaLisbonPortugal

Personalised recommendations